3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
5
Plasma cell
2
Genitourinary
2
Sarcoma
1
Conditions
Prostatic Neoplasms
2
Multiple Myeloma
2
Breast Neoplasms
2
Patient Compliance
1
Osteolysis
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
8
Zoledronic Acid
5
Therapeutics
5
Flow Cytometry
5
pembrolizumab
3
fludarabine
3
Specimen Handling
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Immunologic Techniques
3
Gemcitabine
3
Amplified Fragment Length Polymorphism Analysis
3
venetoclax
2
trametinib
2
ruxolitinib
2
pertuzumab
2
palbociclib
2
liposomal doxorubicin
2
liposomal amphotericin B
2
dabrafenib
2
copanlisib
2
aldesleukin
2
abiraterone
2
Vorinostat
2
Trastuzumab
2
Surveys and Questionnaires
2
Sunitinib
2
Sorafenib
2
Rituximab
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Clodronic Acid
×
Plasma cell
×
Clear all
NCT01198457
2012-09-07
BONA
Bayer
Completed
147 enrolled
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled